TORONTO, ON / ACCESSWIRE / January 10, 2025 / Toggle3D.ai (the "Company") (OTCQB:TGGLF)(CSE:TGGL)(FSE:Q0C), a Nextech3d.ai ...

TORONTO, ON / ACCESSWIRE / January 10, 2025 / ARway.ai("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI ...

The US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix, GSK’s recombinant zoster vaccine for the prevention of ...

GSK PLC GSK shares were unchanged Friday at £13.50, on what proved to be an all-around grim trading session for the stock ...

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

DUPHAT 2025 served as a vibrant platform uniting global and local companies, fostering innovation, creating new business opportunities, and propelling the growth of the UAE's pharmaceutical sector in ...

View the full release here: "I'm excited to welcome Alastair to Chemify to help us with building and scaling our ability to ...

Alzhemier’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.